GAL tanked last couple days coming to the ANN; probably less than ideal news. I guess this makes CNJ more appealing - not knowing the results is better then knowing the drill results are less than expected (GAL), maybe?!
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
